GENF vs. IXI, SNG, BVX, OBD, APTA, CIZ, FAB, HEMO, EVG, and MTFB
Should you be buying Genflow Biosciences stock or one of its competitors? The main competitors of Genflow Biosciences include IXICO (IXI), Synairgen (SNG), BiVictriX Therapeutics (BVX), Oxford BioDynamics (OBD), Aptamer Group (APTA), Cizzle Biotechnology (CIZ), Fusion Antibodies (FAB), Hemogenyx Pharmaceuticals (HEMO), Evgen Pharma (EVG), and Motif Bio (MTFB). These companies are all part of the "biotechnology" industry.
Genflow Biosciences vs. Its Competitors
IXICO (LON:IXI) and Genflow Biosciences (LON:GENF) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.
56.0% of IXICO shares are owned by institutional investors. Comparatively, 9.2% of Genflow Biosciences shares are owned by institutional investors. 30.3% of IXICO shares are owned by insiders. Comparatively, 64.2% of Genflow Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
IXICO has a beta of 0.86, meaning that its stock price is 14% less volatile than the S&P 500. Comparatively, Genflow Biosciences has a beta of 2.37, meaning that its stock price is 137% more volatile than the S&P 500.
In the previous week, IXICO's average media sentiment score of 0.00 equaled Genflow Biosciences'average media sentiment score.
Genflow Biosciences has a net margin of 778.46% compared to IXICO's net margin of -31.10%. IXICO's return on equity of -19.14% beat Genflow Biosciences' return on equity.
Genflow Biosciences has lower revenue, but higher earnings than IXICO. IXICO is trading at a lower price-to-earnings ratio than Genflow Biosciences, indicating that it is currently the more affordable of the two stocks.
Summary
Genflow Biosciences beats IXICO on 6 of the 11 factors compared between the two stocks.
Get Genflow Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for GENF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding GENF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Genflow Biosciences Competitors List
Related Companies and Tools
This page (LON:GENF) was last updated on 7/5/2025 by MarketBeat.com Staff
